GlyCosmos Portal

GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source	Last Updated
PSICQUIC	March 30, 2022

Displaying entries **3451 - 3475** of **4050** in total

« First

‹ Prev

…

135

136

137

138

139

140

141

142

143

…

Next ›

Last »
Antibody	Patient	Onset (days)	Symptom	GlyTouCan ID	Arbitrary Fluorescence Units (AFU) ▼
IgG	Patient 2	24	mild	G29857RC	41
IgM	Patient 2	15	mild	G00051MO	41
IgG	Patient 2	3	mild	G19868AX	41
IgG	Patient 2	3	mild	G43648DB	41
IgG	Patient 3	-180	mild	G67045LB	41
IgG	Patient 3	-180	mild	G86566MF	41
IgG	Patient 3	-180	mild	G89993FE	41
IgG	Patient 3	11	mild	G61751GZ	41
IgG	Patient 3	4	mild	G00051MO	41
IgG	Patient 3	4	mild	G00054MO	41
IgG	Patient 3	4	mild	G25407RZ	41
IgG	Patient 4	12	mild	G57449OF	41
IgG	Patient 1	22	moderate	G53168IY	40
IgG	Patient 1	22	moderate	G58969RU	40
IgG	Patient 1	22	moderate	G61751GZ	40
IgG	Patient 1	22	moderate	G78255UI	40
IgG	Patient 1	22	moderate	G93351GM	40
IgM	Patient 1	10	moderate	G52880ZN	40
IgM	Patient 1	10	moderate	G72739GY	40
IgG	Patient 1	6	moderate	G91537AT	40
IgM	Patient 1	6	moderate	G29011JC	40
IgM	Patient 1	6	moderate	G47566FL	40
IgM	Patient 1	6	moderate	G52880ZN	40
IgM	Patient 1	6	moderate	G62222PE	40
IgG	Patient 2	15	mild	G32699RJ	40